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Abstract
The glycine cleavage system (GCS), the major pathway of glycine catabolism in liver, is found
only in the mitochondria matrix and is regulated by the NAD+/NADH ratio. In conjunction with
serine hydroxymethyltransferase, glycine forms the 1 and 2 positions of serine, while the 3
position is formed exclusively by GCS. Therefore, we sought to exploit this pathway to show that
quantitative measurements of serine isotopomers in liver can be used to monitor the NAD+/NADH
ratio using 13C NMR spectroscopy. Rat hepatocytes were treated with modulators of GCS activity
followed by addition of 2-13C-glycine, and the changes in the proportions of newly synthesized
serine isotopomers were compared to controls. Cysteamine, a competitive inhibitor of GCS,
prevented formation of mitochondrial 3-13C-serine and 2,3-13C-serine isotopomers while reducing
2-13C-serine by 55%, demonstrating that ca 20% of glycine-derived serine is produced in the
cytosol. Glucagon, which activates GCS activity, and the mitochondrial uncoupler carbonyl
cyanide-3-chlorophenylhydrazone (CCCP) both increased serine isotopomers, while rotenone, an
inhibitor of complex I, had the opposite effect. These results demonstrate that 13C MRS
monitoring of the formation of serine isotopomers in isolated rat hepatocytes given 2-13C-glycine
reflects the changes of mitochondrial redox status.
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INTRODUCTION
The redox state of the cell, and in particular the mitochondria, is central to determining
stress and bioenergetic status. In view of this biochemical importance, non-invasive
detection of the NAD+/NADH ratio, the primary redox couple in the mitochondria, was one
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of the first in vivo 13C MRS studies using 13C-labeled nicotinamide as a precursor (1).
Subsequently, in vivo 1H MRS studies monitored redox couples as measures of redox state,
such as lactate/pyruvate and β-hydroxybutyrate/acetoacetate (2). More recently, in vivo 13C
MRS monitored the reduced form of another important redox couple, glutathione, the body’s
primary antioxidant, by infusing 2-13C-glycine (3). The only other major products formed
were various serine 13C isotopomers (3). Since synthesis of these isotopomers depends on
the mitochondrial NAD+/NADH ratio (4–6), they could be used to non-invasively monitor
mitochondrial stress by in vivo 13C MRS.
Glycine is an important reactant in the biosynthesis of serine (Fig. 1A). Glycine
condensation with 5,10-methylene tetrahydrofolate (mTHF) produces serine and
tetrahydrofolate (THF) via serine hydroxymethyltransferase (SHMT, EC 2.1.2.1). This
enzyme has two isoforms, cytosolic SHMT (cSHMT) and mitochondrial SHMT (mSHMT),
located correspondingly in the cytoplasm and the mitochondrial matrix (7). The spatial
separation of these enzymatic activities also is supported by two non-exchangeable pools of
the folate cofactor and participants in these reactions (Fig. 1A). In the cytosol, one-carbon
units converting THF to mTHF are derived primarily from cytoplasmic serine (with
histidine and formate also contributing to the synthesis of methyl group precursors), and in
the mitochondria glycine is the primary source of one-carbon units (8,9) with sarcosine and
dimethylglycine also contributing (10).
Glycine is catabolized in the mitochondrial matrix by the glycine cleavage system (GCS, EC
2.1.2.10), whereby the C-1 of glycine produces CO2 and the C-2 is transferred to THF
(11,12) forming mTHF (Fig. 1B). Because GCS is restricted to the mitochondria (13,14),
and its product mTHF is tightly coupled to mSHMT (15), adding 2-13C-glycine as a
substrate will 13C label mTHF, which donates its 1-C unit via mSHMT, forming four
possible isotopomers: either 2,3-13C-serine, 3-13C-serine, 2-13C-serine or unlabeled serine
(Fig. 1B). The ratios of these serine isotopomers, which have been previously detected
using 13C NMR in yeast (4), rat proximal tubule cells (8,9), and rat livers (3,16), will depend
on the 13C fractional enrichment of 2-13C-glycine (9). One would predict that if serine is
formed from 2-13C-glycine in the cytosol, 2-13C-serine will be the primary isotopomer (Fig.
1B), since in the cytosol mTHF derives its one carbon unit from multiple methyl donors
other than glycine, and would remain unlabeled as long as these methyl donors
remained 13C unlabeled (Fig. 1A). This is in contrast to isotopomers produced in the
mitochondria where the major source of one-carbon units for mTHF is C-2 of glycine.
GCS activity is stimulated by an increased NAD+/NADH ratio (5), hormonally activated by
glucagon (17,18), and absent in diseases such as non-ketotic hyperglycinemia (NKH) (19).
Rotenone, a mitochondrial electron transport chain complex I inhibitor, decreases the
NAD+/NADH ratio (20). Conversely, mitochondrial uncouplers like CCCP increase the
NAD+/NADH ratio (20,21), which increases GCS flux. In this paper we show that
interventions leading to modulation of GCS activity (abrogation with cysteamine (22),
hormonal stimulation by glucagon, or alteration of NAD+/NADH ratio) lead to predictable
changes in intracellular serine isotopomer concentrations, enabling the contributions of
cytosolic and mitochondrial one-carbon donors in cultured hepatocytes to be elucidated.
MATERIALS AND METHODS
Animal housing and care
Male Sprague-Dawley rats (weighing 250–300 g), obtained from Charles River, were
housed and maintained according to the guidelines of the Institutional Animal Care and Use
Committee at the University of North Carolina. Rats were housed in polycarbonate cages
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and given unlimited access to feed (20% crude protein; Agway RMH 3000 rat chow) and
water.
2D Culture of isolated rat hepatocytes
Rat hepatocytes were isolated using a standard collagenase digestion protocol as described
previously (23). Following intraperitoneal injection of pentobarbital, the liver of the
anesthetized rat was accessed through abdominal incision and retrograde perfused with
buffer A (in mM: 5 KCl, 115 NaCl, 25 HEPES, 1 KH2PO4, 2.5 MgSO4, 0.5 EGTA, pH 7.4)
at flow rate 25 ml/min for 6 min. Immediately afterward the liver was digested with
perfusion buffer B (in mM: 5 KCl, 115 NaCl, 25 HEPES, 1 KH2PO4, 2 CaCl2, pH 7.4)
containing 0.1 mg/mL collagenase (Sigma) at a flow rate of 25 ml/min for 13 min. After
digestion the hepatocytes were dislodged and centrifuged 3 times in cold perfusion buffer.
Viability of hepatocytes was then determined, and the cells were resuspended at 1.5 × 106
viable cells/mL in plating media (DMEM high glucose with L-glutamine and pyruvate plus
10% FBS, 100 U penicillin/streptomycin, 140 nM insulin, and 1 µM dexamethasone). The
plates were coated with 9.5 mL of a 0.1% acetic acid solution containing 0.1% type I
collagen isolated from rat tail tendons according to (24) in 0.1% acetic acid and dried
overnight under UV. Hepatocyte suspensions with viability greater than 80% were used to
plate 145 cm2 collagen-coated plates (Nunclon dishes, #168381) using 10 ml of suspension
(total of 1.5 × 107 cells per plate). After 1–2 h of incubation the media containing
unattached/dead cells was removed and replaced with fresh plating media. After overnight
incubation, hepatocyte plating media was then replaced with 10 mL of test media (plating
media minus insulin) containing appropriate drug. For all experiments glucagon is used at
100 nM, cysteamine at 500 µM, CCCP at 5 µM, rotenone at 50 µM and ethanol at 100 mM.
After a 2 h incubation in test media +/− drug, incubation media was supplemented with 5
mM 2-13C-glycine (Cambridge Isotope Laboratories, MA and Isotec Inc., Miamisburg, OH)
and cells were incubated in the presence of 2-13C-glycine for 3 h. This time was chosen
because preliminary experiments demonstrated that glycine and serine isotopomers had
achieved steady state levels by 3 h (see Supplemental Fig. 1), as well as in vivo (25). For
range-finding studies to determine the effect of glucose on 13C serine isotopomer formation,
high (25mM, 4.5 g/L), medium (11 mM, 2g/L), and low (5.5 mM, 1 g/L) concentrations of
U-13C-glucose (Isotec Inc., Miamisburg, OH) was added to DMEM and used as the test
media. At the end of each rat hepatocyte experiment, a plate was used to obtain protein
content. The plate was washed three times with cold PBS and 10 mL of cold lysis buffer (25
mM Hepes, 5 mM CHAPS, 5 mM DTT, pH 7.4) was put on the plate. After 20 min in the
lysis buffer, the protein content was assessed by the Bradford method as described by the
manufacturer (Pierce Biotechnology, IL).
Preparation of NMR samples
After 3 h of 2-13C glycine labeling, the hydrophilic portion of cytosol was obtained using a
methanol:water:chloroform (1:1:1, v/v) extraction according to Winnike and others (26).
Briefly, cells were washed five times with ice-cold 1× PBS and then 5 mL of ice-cold
methanol was added to each plate. Cells were dislodged using a cell scraper and the contents
of the plate were transferred into a centrifuge tube. Water (5 mL) was then added to each
plate to remove any remaining material and combined with methanol. To the water/methanol
extract of the cells from each plate an equivalent volume (5 ml) of chloroform was added
and the mixture was shaken vigorously for 5 min then stored overnight at 4°C. The next day
samples were centrifuged at 5,000 × g for 30 minutes and the upper (non-chloroform) layer
was transferred into a clean tube and lyophilized. Samples were stored at 4°C until NMR
analysis.
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13C and 1H NMR spectroscopy and serine isotopomer analysis
Lyophilized samples were resuspended in 700 µL of deuterium oxide containing 1 mM TSP
and 3 mM 2-13C acetate. After centrifugation, supernatants were transferred to 5 mm NMR
tubes. One pulse 13C spectra with 1H decoupling during acquisition were obtained on a
Varian 14.1T (600 MHz 1H frequency) spectrometer at 25° C using a 5 mm Varian HCN
indirect detection probe with spectral width of 32,000 Hz, acquisition time of 2 s, complex
points of 64,000, an interpulse delay of 2 s, and 640 transients. The 13C channel was
observed and 1H decoupled. All spectra were analyzed using ACD’s 1D NMR Processor
software (ACD Labs, Toronto, Canada). The peak area of each 13C metabolite relative to the
peak area of the 2-13C-acetate standard was then divided by the corresponding control value
of this ratio to obtain a percent change from control.
Glycine concentration was quantified from the 1H spectra which was acquired using a one
pulse seuence with presataturation of the water resonance using a 90° flip angle, and a total
repetition time (TR) of 12.65 s. The peak areas in the 1H spectra were determined using the
Chenomx NMR processing spoftware v 7.1 (Edmonton, Alberta, Canada). First, spectra
were zero-filled to 32,000 points, and line broadened using a 0.5 Hz exponential Gaussian
function. Concentrations were calculated from the 1H spectra by comparing the peak areas
to the internal concentration standard, 2,2’,3,3’ duetero-trimethyl propionate (TSP). Serine
isotopomer concentration was obtained from 13C NMR spectrum as described above
because the region where serine resonates in the 1H spectrum is extremely crowded and is
additionally confounded by ABC homonuclear scalar coupling and one and two bond
heteronuclear coupling.
Confocal microscopy
After overnight incubation, MatTek dishes containing hepatocytes were placed on the stage
of a Zeiss 510 LSM confocal microscope (Carl Zeiss, Thornwood, NY, USA) in an
environmental chamber (37° C, 5% CO2, 95% air, 100% humidity) for imaging of
intracellular NADH. Plating media was replaced with test media and NADH fluorescence
was visualized with a 63X N.A. 1.4 planapochromat oil immersion lens using the 720 nm
line of a Chameleon laser set to 5% attenuation for excitation and emission light was
collected using LP470 long pass filter. Following acquisition of the initial images of cells,
the appropriate drug was added into the incubation media and hepatocytes were incubated
for 60 min, at which time NADH fluorescence of hepatocytes was recorded. Mean intensity
of the fluorescence was obtained by averaging the blue (NADH) fluorescence of at least 10
cells from 3 different fields using Adobe Photoshop’s histogram function (Adobe, Inc., San
Jose, CA).
Unfortunately, NADH is oxidized in low pH (27), phosphate buffer (28), during freezing
(29), and freeze-drying, all of which were part of the hepatocyte extraction procedure. The
redox pair, pyruvate/lactate, is a measure of the NADH/NAD+ ratio in the cytosol but not
the mitochondria where the serine isotopomers are formed (27). The redox couple of
acetoacetate/β-hydroxybutyrate is a measure of mitochondrial redox, and similar to the keto
acid pyruvate (30), acetoacetate is also unstable (27) with 40% decarboxylating after 7 days
of storage at −20° C (31). However, the in vivo NADH fluorescent measurement is the gold
standard, and the ultimate validation, of all of the in vitro analytical methods for determining
the NADH/NAD+ ratio (27–29). Therefore, it is qualitatively superior for the in situ redox
state compared to any in vitro measure of NADH/NAD+ ratio since there is no sample
preparation. However, the quantitative NADH/NAD+ ratio was not obtained, since cultures
in parallel exclusively for in vitro analysis were not part of the experimental design, and thus
correlating redox state to serine isotopomer ratio is qualitative.
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Results are expressed as mean ± standard error mean. Significance was determined using
GraphPad Prism (GraphPad Software, La Jolla, CA) to perform a one-way ANOVA with
Dunnett’s post hoc correction, to compare serine isotopomers, glycine, and glutathione
concentrations from each treatment condition to control.
RESULTS
Preliminary studies of hepatocytes cultured in DMEM media containing 25 mM, 12 mM,
and 5 mM glucose with 5 mM 2-13C-glycine demonstrated that only DMEM containing 5
mM glucose resulted in 13C-labeling of serine isotopomer ratios (data not shown) similar to
that found with in vivo rat studies (3). Using this low glucose media formulation, label was
incorporated into 2-13C-serine, 2,3-13C-serine, 3-13C-serine, and [2-13C-glycyl]glutathione.
A representative 13C spectrum of hepatocytes administered 2-13C-glycine is shown in figure
2. The inset 13C NMR spectrum displays the region of interest with peaks for 2-13C-serine
and 3-13C-serine isotopomers represented as the singlets centered at 57 ppm and 61 ppm,
respectively. Two doublets, symmetrically centered at 57 ppm and 61 ppm, reflect the
presence of 2,3-13C-serine isotopomers in the extract (shown in Fig. 2, expanded regions at
57 ppm and 61 ppm), demonstrating relative abundances of these isotopomers in the extract.
The 13C NMR spectrum revealed minor labeling of the C-2 of aspartate and glutamate at
53.2 ppm and 55.2 ppm, respectively, with similar relative triplet intensities as serine,
indicating that 2-13C-, 3-13C-, and 2,3-13C-isotopomers of aspartate and glutamate all
formed from serine produced in the mitochondria. Not shown is the downfield portion of
the 13C NMR spectrum, which demonstrated that the methyl of methionine (C-4 position)
resonating at 17.2 ppm is not detected (see Discussion).
Figure 3 illustrates the effect of cysteamine (500 µM), a selective inhibitor of GCS (22), and
glucagon (100 nM), a known activator of GCS (18), on the peak areas of serine isotopomers
as scaled to the control 13C NMR spectrum. Cysteamine completely eliminated the two
doublet peaks representing the GCS-dependent generation of 2,3-13C-serine and the 3-13C-
serine singlet peak, leaving a small portion of the cytosolic-derived 2-13C-serine singlet
peak (Fig. 1B). In contrast, glucagon increased all of these peaks indicating increased
activity of GCS. Cysteamine is a thiol-containing reducing agent and this property, rather
than its GCS inhibitory activity, may influence the serine labeling. To check for this, N-
acetylcysteine, a thiol-containing reductant with similar properties to cysteamine but lacking
GCS-inhibitory activity, was added at a concentration of 5 mM without altering the serine
isotopomer labeling patterns (data not shown).
Figure 4A quantifies the changes in the serine isotopomers due to the various treatments
relative to control (no treatment). In general, significant changes were quantified in 2,3-13C-
serine and 3-13C-serine, but not 2-13C serine. Cysteamine decreased 2-13C-serine 45%
relative to control levels and abrogated production of both mitochondrial isotopomers (p <
0.001). Glucagon caused a 66%, 213%, and 148% increase in 2-13C serine, 2,3-13C-serine,
and 3-13C-serine, respectively, as a result of hormonal activation of the GCS (p< 0.01).
Rotenone, which blocks mitochondrial complex I resulting in a build-up of NADH, caused a
decrease in 2-13C-serine, 2,3-13C serine, and 3-13C-serine by 7%, 40% and 50%,
respectively (p < 0.05 for 2,3-13C serine and p = ns for 2-13C-serine). The mitochondrial
uncoupler CCCP, known to oxidize mitochondrial NADH (20,21) and increase NAD+
concentrations in the mitochondrial matrix, increased production of serine isotopomers.
Although treatment with CCCP did not significantly increase 2,3-13C-serine (p > 0.05; n=4)
nor did another mitochondrial uncoupler, 2,4-dinitrophenol (p > 0.05; n=3; data not shown),
there is a strong trend for uncouplers to increase mitochondrial serine isotopomers.
Similarly, ethanol decreased synthesis of 2-13C-serine, 2,3-13C serine, and 3-13C-serine in
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hepatocytes by 26%, 26% and 46%, respectively, although it did not quite reach significance
once the Dunnett correction was applied (p>0.05; n=8). Taken together these results
demonstrate that modulators of GCS activity cause greater changes in the synthesis of
3-13C-serine and 2,3-13-C-serine as compared with production of 2-13C-serine.
The effects of the six drugs on metabolism of 13C-labeled glycine and glutathione levels as
compared to controls (i.e., no treatment) are shown in Figure 4B. Cysteamine increased
production of glycine and glutathione by 126% and 38%, respectively. Glucagon has little
effect on glycine and glutathione. Similar to glucagon, CCCP has minimal effect on
glutathione, but decreased glycine by 17%, and DNP decreased glycine by 26% (Fig. 4B).
Rotenone increased glycine by 63% while decreasing glutathione by 32%. Ethanol exposure
increased glycine and to a lesser extent glutathione by 53% and 17%, respectively, though
both results were not significant. In general, the magnitudes of the changes in glycine
induced by the modulators (Fig. 4B) tracks the changes in the serine isotopomers (Fig. 4A).
Confocal imaging of NADH autofluorescence has been shown to be a sensitive indicator of
mitochondrial redox state (32). Imaging of intracellular NADH fluorescence confirmed that
rotenone and the uncoupler CCCP, as shown in figure 5, substantially altered NAD+/NADH
ratio as demonstrated by decreased level of NADH fluorescence in the presence of CCCP
and increased fluorescence of NADH in cells treated with rotenone (Fig. 5, compare
Control, CCCP and Rotenone). Since rotenone selectively blocks mitochondrial electron
transport chain at the level of Complex I it causes a build-up of NADH, an effect evidenced
under our conditions by an increased mean fluorescence intensity of mitochondrial NADH
by 21 relative fluorescent units (RFUs) (Fig. 5, compare Control and Rotenone). In
contrast, the uncouplers of oxidative phosphorylation, DNP and CCCP, are known to cause
oxidation of NADH and increase NAD+ concentrations (Fig. 5, compare Control and
CCCP).
DISCUSSION
These results present a novel insight into the expanded use of MRS to probe mitochondrial
function. The effects of cysteamine, glucagon, rotenone, ethanol, and uncouplers on GCS
activity are known (22,33), and the serine isotopomer data shown in figure 4A corroborates
what is known about the effect of these toxins or hormones on the GCS. This data, obtained
from 2-D hepatocyte cultures, combined with previous in vivo work from our lab (3),
suggests that monitoring serine isotopomers after 2-13C glycine infusion is a novel research
tool to probe changes in mitochondrial redox state.
Ex Vivo Replication of In Vivo Serine 13C Isotopomer Ratios
Typical cell culture contains 25 mM glucose and 100 unit/L insulin, or nearly 3-fold and 3
orders of magnitude higher than physiological serum levels, respectively; therefore, initial
glucose concentration range-finding studies were performed to recreate conditions that
would replicate in vivo serine 13C isotopomer ratios. Previous NMR studies have used 5
mM to 7 mM glucose in cell culture (34) and primary tissues (8,9) to study the formation of
serine 13C isotopomer from 2-13C-glycine. In rat hepatocytes, similar serine 13C isotopomer
ratios as found in vivo (3) were formed using media containing 5 mM glucose. In fact, no
serine 13C isotopomers were detected with 11 mM or 25 mM glucose culture conditions.
The use of media containing 5 mM glucose showed decreased steady-levels of glucose and
glucose-derived glycolytic end-products, such as alanine and lactate (data not shown), and
represents the starved state using rat hepatocyte cultures (26). In this state, amino acids like
glycine can act anaplerotically via formation of serine by cSMHT (14), in the absence of
other energy carbon sources like glucose.
Johnson et al. Page 6













Compartmentation of Serine Biosynthesis
If all of the serine isotopomers were formed in the mitochondria from 2-13C-glycine then the
triplets representing the C3 and C2 of serine at 61.3 ppm and 57.2 ppm, respectively, would
be identical (Fig. 3), but there is ca 20% more 2-13C-serine at 57.2 ppm (Fig. 3, inset). This
is similar to the serine 13C isotopomer ratio found in liver from intact rat intravenously
infused with 2-13C-glycine (3). Depending on conditions, others have found 20–30% of
SHMT activity in hepatocytes is cytosolic, while 70–80% is mitochondrial (5,7,18,35). In
order to test the hypothesis that about 20% of glycine-derived serine was formed in the
cytosol, hepatocytes were treated with a competitive inhibitor of GCS, cysteamine, which
abrogated production of both mitochondrial isotopomers, 3-13C-serine and 2,3-13-C-serine
(Fig. 4A). This demonstrates that under these experimental conditions the GCS is the sole
route for synthesis of these two serine isotopomers from 2-13C-glycine. In fact, the increase
of 127% in glycine level relative to the control (Fig. 4B) suggests an intracellular
accumulation of this GCS substrate demonstrating that glycine catabolism is primarily
mitochondrial under these experimental conditions (Fig. 1A).
This discovery must mean that the cytosolic mTHF is unlabeled, and exchange of
mitochondrial-derived serine and mTHF-derived formate with subsequent 13C-labeling of
the cytosolic mTHF pool (Fig. 1A) was not detected in these studies. Unlabeled serine and
2-13C-glycine were included in the basal media at a concentration of 0.4 mM and 5 mM,
respectively, which would favor the forward reaction of cSHMT producing unlabeled 2-13C-
serine, assuming mTHF is unlabeled (36). Finding that cysteamine completely eliminated de
novo formation of the 3-13C-serine and 2,3-13-C-serine would also imply that there is no
detectable transport of GCS-derived formate from the mitochondria to the cytosol with
subsequent incorporation into cytosolic mTHF under these experimental conditions (37).
This demonstrates compartmental metabolic production of serine in rat hepatocytes (36), as
was shown in yeast (38), kidney slices (8,9) and mice (39).
Methionine and S-adenosylmethionine form the primary methylating compounds of the
cytosol (10,40,41) and under elevated concentrations will form sarcosine and other
methylating agents that can enter the mitochondria to produce mTHF (Fig. 1A) (42).
Unlabeled methionine is included in the basal media at a concentration of 0.2 mM and 13C
labeling of the methyl (C5) of methionine was not detected in the 13C spectrum (see
Results). However, under elevated levels of methionine poisoning, glycine-derived cytosolic
sarcosine can become a major methyl donor in mitochondria (42), and could possibly alter
the serine isotopomer ratios. In this study methionine was maintained at relatively nontoxic
levels.
Relationship between Serine Isotopomers and NAD+/NADH Ratio
Formation of 2,3- and 3-13C-serine from 2-13C-glycine requires transfer of the 2-C from
glycine to THF via GCS and subsequent transfer of the labeled mTHF 1-C unit to a second
labeled or unlabeled glycine via mSHMT. The GCS is dependent on redox state, but
mSHMT is not. Instead mSHMT is a reversible enzyme, the direction of which is
determined by the concentrations of the reactants glycine and 5,10-mTHF (6). Importantly,
the activities of GCS and mSHMT have been shown to be tightly coupled (9,15). Thus an
increase in the NAD+/NADH ratio will drive the GCS, which will concomitantly increase
flux through mSHMT, making regulation of GCS via redox state directly responsible for
mitochondrial serine isotopomer production.
Rotenone inhibits mitochondrial complex I resulting in a build-up of NADH, which would
inhibit GCS (5). The confocal images shown in figure 5 support the claim that rotenone
increases NADH in the hepatocytes. Amongst the drugs used in this paper, the relatively
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large increase in glycine and decrease in glutathione is a unique effect of rotenone, likely a
combination of decreased GCS activity (thus glycine accumulation) and increased reactive
oxygen species generation (thus lower glutathione) (43). Ethanol is known to decrease the
mitochondrial NAD+/NADH ratio (44) and was shown to decrease mitochondrial serine
isotopomers (Fig. 4A). In addition, ethanol increases glycine and to a lesser extent
glutathione levels, probably due to funneling of glycine through alternate pathways
secondary to GCS activity; however, other ideas, including voltage dependent anion channel
modulation, have been proposed to describe ethanol’s effects on 13C-glycine metabolism
(45).
Potential Clinical Use of 13C Spectroscopy for Monitoring the GCS
Glucagon’s hormonal effect on GCS was demonstrated with significant increases in
mitochondrial serine isotopomers (Fig. 4A) yet no effect on glycine and glutathione levels
(Fig. 4B). Glucagon has been shown to activate GCS hormonally (17), but this process is
sensitive to high NADH levels, as rotenone significantly decreased GCS flux (33).
Therefore, despite the fact that the GCS is modulated by hormonal state, pathologic
conditions that decrease the NAD+/NADH ratio would override the elevated glucagon
levels, still leading to decreased production of GCS-specific serine isotopomers.
Compared to earlier techniques of monitoring GCS activity, which mostly relied on
radioactive 14C (33), use of 13C spectroscopy can be translated into clinical use. Other
techniques used to monitor GCS activity in vivo include the 13C breath test (46), which has
the advantage of also being non-invasive, and direct venous infusion of 13C glycine (35),
which provides information about glutathione and redox status but is invasive; however,
both of these techniques fail to provide the spatial information that MRS can. Therefore, 13C
spectroscopy may hold the greatest clinical promise for directly examining GCS activity.
Despite its low sensitivity compared to 1H, in vivo 13C MRS has been successfully used to
study metabolic pathways in normal and disease physiology (47), but the absolute
quantification of the experimental results is not trivial with both stable and
hyperpolarized 13C isotope methods (48). In figure 4B, we reported the results in terms of
change in the peak areas representing the various serine isotopomers relative to control,
which can potentially be applied to in vivo MRS results without elaborate calibration or
assumptions. The extra concern of this method is the peak separation of the serine
isotopomers in the in vivo spectra. The carbon-carbon one bond coupling constant is about
37 Hz in for 2,3-13C-serine, which is about 0.5 ppm at 7T and 2.3 ppm at 1.5T. It has been
shown that it is possible to obtain excellent peak quantification results even from peaks only
with 0.14ppm separation from the rat liver at 7T, using routine deconvolution of overlapping
peaks (49). Therefore, it is reasonable to assume that the relative peak ratio quantification in
this study would be enough to produce conclusive results when 13C glycine is used in in
vivo human and animal MRS experiments. For example, we also speculate that this
approach may be clinically relevant in diagnosing NKH, which currently requires a liver
biopsy to diagnose definitively (50).
In conclusion, we show that monitoring the mitochondrial redox state is possible via 13C
MRS using 2-13C-glycine as a substrate.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The various fates of 2-13C-glycine in rat hepatocytes (A), and the formation of 2-13C-serine
and 3-13C-serine isotopomers in the cytosol and mitochondria, respectively (B). Number “2”
indicates the position of the 13C atom in glycine that is transformed to 13C-serine by
cSHMT, while GCS transfers 2-13C of glycine to form mTHF, a cofactor of serine
hydroxymethyl transferase (mSHMT), which condenses labeled mTHF with another
molecule of glycine or 2-13C-glycine producing 3-13C-serine and 2,3-13C-serine,
respectively. When 2-13C-glycine reacts with unlabeled mTHF in the mitochondria 2-13C-
serine will form in the same proportion as 3-13C-serine (B). Abbreviations: Gly, glycine;
Ser, serine; DMG, dimethylglycine; Bet, betaine; chol, choline; Sarc, sarcosine; Form,
formate; Hcy, homocysteine; Met, methionine; THF, tetrahydrofolate; mTHF, 5,10-
methylene-THF; cSHMT, cytosolic serine hydroxymethyltransferase; GCS, glycine
cleavage system; mSHMT, mitochondrial serine hydroxymethyltransferase; MS*,
methionine synthetase (the asterisk denotes that this enzyme requires 5-methyl-THF, not
5,10-methylene-THF as the figure indicates); GNMT, glycine N-methyltransferase; BHMT,
betaine-homocysteine methyltransferase; SDH, sarcosine dehydrogenase (note the cofactor
is mTHF); DMGDH, dimethylglycine dehydrogenase (note the cofactor is mTHF); B-A DH,
betaine-aldehyde dehydrogenase (FADH is the cofactor); CDH, choline dehydrogenase
(FADH is the cofactor); 1, 5,10-methylene-THF dehydrogenase; 2, 5,10-methenyl-THF
cyclohydrolase; 3, 10-formyl-THF synthetase; 1–3 are catalyzed by trifunctional C1-THF
synthase (MTHFD1) in the cytoplasm; 1m and 2m are bifunctional MTHFD2 or
MTHFD2L; 3m, monofunctional MTHFD1L [1–3 and 1m–3m from (37)].
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Representative 13C spectra from rat hepatocyte extraction after 2 h 2-13C-glycine treatment.
The inset shows the region from 56 – 61 ppm in greater detail.
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Representative 13C spectra from hepatocytes treated with 100 nM glucagon, 500 µM
cysteamine, 5 µM CCCP, and 50 µM rotenone.
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Effect of glucagon (n=4), cysteamine (n=3), CCCP (n=4), rotenone (n=4), and ethanol (n=8)
on 13C-labeled serine isotopomers (A) as well as 13C glycine and glutathione concentrations
(B) as compared to control (n=7). Values are mean ± SEM from independent experiments
(number, n, for each treatment listed above). The level of significance was determined by
one-way ANOVA with Dunnett’s correction for multiple comparisons and given in the text.
Johnson et al. Page 15














Representative confocal images showing blue NADH fluorescence (A) and the
corresponding mean emission intensities ± SEM from n = 3 fields (B) for control, CCCP and
rotenone treated hepatocytes.
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